Category history - Physiology Practice
From WikiLectures
| Time | Page Name | Author of this revision | Description | Flags |
|---|---|---|---|---|
| 2024-02-04 10:00 | Warfarin | Jakub Jan Kvašňák | ||
| 2024-01-10 20:12 | Anticoagulants | Beloslava Erofeeva | added categories | |
| 2023-10-02 19:47 | Haemocoagulation versus anticoagulation | Ahmed Bahaa Chaban | ||
| 2023-03-24 14:31 | Thromboembolic disease | Michael Hartig | Checked by editor | |
| 2023-03-17 19:07 | Thromboembolic disease | Layan Tamraz | /* Acquired predisposition */ | |
| 2023-03-17 19:05 | Thromboembolic disease | Layan Tamraz | /* Acquired predisposition */ | |
| 2023-03-17 19:05 | Thromboembolic disease | Layan Tamraz | /* Differential diagnosis */ | |
| 2023-03-17 19:04 | Thromboembolic disease | Layan Tamraz | /* Differential diagnosis */ | |
| 2023-03-17 19:03 | Thromboembolic disease | Layan Tamraz | /* References */ | |
| 2023-03-17 19:01 | Thromboembolic disease | Layan Tamraz | /* Differential diagnosis */ | |
| 2023-03-17 19:01 | Thromboembolic disease | Layan Tamraz | /* Differential diagnosis */ | |
| 2023-03-17 18:59 | Thromboembolic disease | Layan Tamraz | /* Differential diagnosis */ | |
| 2023-03-16 19:43 | Thromboembolic disease | Layan Tamraz | /* External links */ | |
| 2023-03-16 19:42 | Thromboembolic disease | Layan Tamraz | ||
| 2023-03-16 19:38 | Thromboembolic disease | Layan Tamraz | /* References */ | |
| 2023-03-16 19:38 | Thromboembolic disease | Layan Tamraz | /* Links */ | |
| 2023-03-16 19:32 | Thromboembolic disease | Layan Tamraz | me | |
| 2023-03-16 18:26 | Thromboembolic disease | Layan Tamraz | ||
| 2023-03-16 18:25 | Thromboembolic disease | Layan Tamraz | From https://www.wikiskripta.eu/index.php?curid=11835 | |
| 2023-02-21 13:05 | The renin-angiotensin-aldosterone system | a | ||
| 2023-01-29 12:54 | Goldmann equation | Scarlatina | ||
| 2023-01-17 01:17 | The renin-angiotensin-aldosterone system | Eliška Mynářová | ||
| 2023-01-17 01:14 | The renin-angiotensin-aldosterone system | Eliška Mynářová | ||
| 2023-01-14 20:24 | Comparision of certain blood tests | Leona Hrubá | Checked by editor | me |
| 2023-01-07 17:14 | Comparision of certain blood tests | Vít Křivan | me | |
| 2023-01-07 17:11 | Comparision of certain blood tests | Vít Křivan | Translated from czech original site | |
| 2023-01-04 20:08 | Haemocoagulation versus anticoagulation | Veronika Jarošová | Checked by the editor | |
| 2023-01-04 18:45 | Coagulation versus agglutination | Veronika Jarošová | Checked by the editor | |
| 2023-01-04 18:42 | Goldmann equation | Scarlatina | ||
| 2023-01-04 18:41 | Goldmann equation | Scarlatina | ||
| 2023-01-04 18:40 | Goldmann equation | Scarlatina | Created page with "__NOTOC__ also the Goldman-Hodgkin-Katz equation * Allows calculation of membrane potential based on intracellular and extracellular ion concentrations, * based on Nernst e..." | |
| 2023-01-04 15:07 | Haemocoagulation versus anticoagulation | Satková Petra | ||
| 2023-01-04 15:05 | Haemocoagulation versus anticoagulation | Satková Petra | Original text was from WikiSkripta: Hemokoagulace versus antikoagulace (https://www.wikiskripta.eu/w/Hemokoagulace_versus_antikoagulace) | |
| 2023-01-04 08:57 | Transport across cell membrane | |||
| 2023-01-03 14:22 | The renin-angiotensin-aldosterone system | |||
| 2023-01-03 12:59 | Coagulation versus agglutination | Satková Petra | ||
| 2023-01-03 12:48 | Coagulation versus agglutination | Satková Petra | Original text was from WikiSkripta: Koagulace versus aglutinace (https://www.wikiskripta.eu/w/Koagulace_versus_aglutinace) | |
| 2022-12-30 18:05 | Warfarin | Ellpa | ||
| 2022-12-30 18:03 | Warfarin | Ellpa | ||
| 2022-12-30 18:01 | Warfarin | Ellpa | ||
| 2022-12-30 18:00 | Warfarin | Ellpa | ||
| 2022-12-30 17:13 | Warfarin | Ellpa | ||
| 2022-12-30 17:03 | Warfarin | Ellpa | ||
| 2022-12-30 16:21 | Transport across cell membrane | Ellpa | ||
| 2022-12-30 16:17 | Transport across cell membrane | Ellpa | ||
| 2022-12-30 15:52 | Transport across cell membrane | Ellpa | ||
| 2022-12-30 15:49 | Transport across cell membrane | Ellpa | ||
| 2022-12-30 15:48 | Transport across cell membrane | Ellpa | Created page with "__TOC__ [[Cell membrane]] is '''semipermeable'''. Substances that pass through it can pass freely or with the help of membrane carriers. Substance transport can then be '''act..." | |
| 2022-12-30 14:17 | Warfarin | Eliška Kočíková | Blanked the page | |
| 2022-12-30 14:01 | Warfarin | Eliška Kočíková | ||
| 2022-12-30 13:50 | Warfarin | Eliška Kočíková | ||
| 2022-12-30 13:47 | Warfarin | Eliška Kočíková | ||
| 2022-12-30 13:39 | Warfarin | Eliška Kočíková | Original text was from WikiSkripta: Warfarin (https://www.wikiskripta.eu/index.php?title=Warfarin&action=edit) | |
| 2022-12-28 21:40 | The renin-angiotensin-aldosterone system | Eliška Mynářová | Original text was from Wikiskripta Renin-angiotenzin-aldosteronový systém (https://www.wikiskripta.eu/index.php?curid=11816) | |
| 2022-12-28 21:39 | The renin-angiotensin-aldosterone system | Eliška Mynářová | ||
| 2022-12-28 21:37 | The renin-angiotensin-aldosterone system | Eliška Mynářová | ||
| 2022-12-28 21:35 | The renin-angiotensin-aldosterone system | Eliška Mynářová | ||
| 2022-12-28 21:34 | The renin-angiotensin-aldosterone system | Eliška Mynářová | ||
| 2022-12-28 21:33 | The renin-angiotensin-aldosterone system | Eliška Mynářová | ||
| 2022-12-28 21:31 | The renin-angiotensin-aldosterone system | Eliška Mynářová | Created page with "__NOTOC__ The '''Renin-angiotensin-aldosterone system'''' (RAAS, renin-angiotensin-aldosterone axis) is one of the main '''neurohumoral'' regulators of ''physiological Home..." | |
| 2022-12-28 14:57 | Adipose tissue hormones | Veronika Jarošová | Checked by the editor | |
| 2022-12-27 20:46 | Adipose tissue hormones | Tereza Ribarova | original text - https://www.wikiskripta.eu/index.php?curid=20746 | |
| 2022-12-23 20:21 | Tromboembolic disease | |||
| 2022-12-23 19:07 | Tromboembolic disease | Martin Hájek | /* Literature used */ | |
| 2022-12-23 19:04 | Tromboembolic disease | Martin Hájek | /* Literature used */ | |
| 2022-12-23 18:58 | Tromboembolic disease | Martin Hájek | /* Literature used */ | |
| 2022-12-23 18:41 | Tromboembolic disease | Martin Hájek | /* Literature used */ | |
| 2022-12-23 18:41 | Tromboembolic disease | Martin Hájek | /* Literature used */ | |
| 2022-12-23 18:40 | Tromboembolic disease | Martin Hájek | /* Literature used */ | |
| 2022-12-23 18:36 | Tromboembolic disease | Martin Hájek | /* Literature used */ | |
| 2022-12-23 18:27 | Tromboembolic disease | Martin Hájek | /* Literature used */ | |
| 2022-12-23 18:26 | Tromboembolic disease | Martin Hájek | /* Literature used */ | |
| 2022-12-23 18:25 | Tromboembolic disease | Martin Hájek | /* Literature used */ | |
| 2022-12-23 18:20 | Tromboembolic disease | Martin Hájek | ||
| 2022-12-23 17:43 | Tromboembolic disease | Martin Hájek | ||
| 2022-12-23 17:40 | Tromboembolic disease | Martin Hájek | /* External links */ | |
| 2022-11-10 17:03 | Tromboembolic disease | Martin Hájek | ||
| 2022-11-09 21:30 | Tromboembolic disease | Martin Hájek | The original is from wikiskripta: https://www.wikiskripta.eu/index.php?curid=11835 | |
| 2022-11-09 21:27 | Tromboembolic disease | Martin Hájek | ||
| 2022-11-09 09:50 | Tromboembolic disease | Martin Hájek | Created page with "__TOC__ Jako trombembolická nemoc (TEN) se označuje '''skupina trombofilních stavů''' a jejich důsledky: * tepenné [[trombosa|tromby]] a [[embolie]], * tromboflebitidy,..." | |
| 2022-04-13 13:21 | AB0 incompatibility/comments | Andrea Rashovska | checked by the editor | |
| 2022-04-11 16:02 | AB0 incompatibility/comments | Natálie Šmachová | /* Natural antibodies */ | |
| 2022-04-11 16:01 | AB0 incompatibility/comments | Natálie Šmachová | ||
| 2022-04-11 15:57 | AB0 incompatibility/comments | Natálie Šmachová | Original text was from WikiSkripta AB0 inkompatibilita/poznámky https://www.wikiskripta.eu/index.php?curid=2257 | |
| 2022-02-19 15:15 | Anticoagulants | Kassandra Beltran | me | |
| 2022-02-10 22:45 | Anticoagulants | David Kolář | ||
| 2022-01-29 12:18 | Anticoagulants | David Kolář | ||
| 2022-01-29 12:17 | Anticoagulants | David Kolář | ||
| 2022-01-29 12:05 | Anticoagulants | David Kolář | ||
| 2022-01-29 12:03 | Anticoagulants | David Kolář | ||
| 2022-01-29 12:03 | Anticoagulants | David Kolář | /* Pentasaccharides */ | |
| 2022-01-29 11:57 | Anticoagulants | David Kolář | ||
| 2022-01-29 11:53 | Anticoagulants | David Kolář | ||
| 2022-01-29 11:47 | Anticoagulants | David Kolář | ||
| 2022-01-29 11:37 | Anticoagulants | David Kolář | ||
| 2022-01-07 23:31 | Anticoagulants | David Kolář | ||
| 2022-01-07 23:30 | Anticoagulants | David Kolář | ||
| 2022-01-07 22:59 | Anticoagulants | David Kolář | ||
| 2022-01-07 14:19 | Anticoagulants | David Kolář | ||
| 2022-01-07 14:13 | Anticoagulants | David Kolář | ||
| 2022-01-07 13:37 | Anticoagulants | David Kolář | ||
| 2022-01-07 13:24 | Anticoagulants | David Kolář | Created page with "__TOC__ '''Antikoagulancia''' jsou léčiva snižující [[Hemokoagulace|srážlivost krve]]. Svým působením blokují [[koagulační faktory]], a tím i vlastní koagulaci..." | |
| 2021-12-07 11:41 | Heparin | Andrea Rashovska | checked by the editor | |
| 2021-12-06 17:12 | Heparin | Damon Richter | Oprava | me |
| 2021-12-06 17:11 | Heparin | Damon Richter | Citace | |
| 2021-12-05 16:10 | Heparin | Damon Richter | Citace - final | me |
| 2021-12-05 16:09 | Heparin | Damon Richter | Citace - final? | me |
| 2021-12-05 16:08 | Heparin | Damon Richter | Citace | me |
| 2021-12-05 16:07 | Heparin | Damon Richter | Citace | me |
| 2021-12-05 16:05 | Heparin | Damon Richter | Citace | me |
| 2021-12-05 16:03 | Heparin | Damon Richter | Citace | me |
| 2021-12-05 16:01 | Heparin | Damon Richter | Citace | me |
| 2021-12-05 15:58 | Heparin | Damon Richter | Citace-opět | me |
| 2021-12-05 15:52 | Heparin | Damon Richter | Citace | me |
| 2021-12-05 15:51 | Heparin | Damon Richter | Citace | me |
| 2021-12-05 15:47 | Heparin | Damon Richter | Citace | me |
| 2021-12-05 15:44 | Heparin | Damon Richter | Citace | me |
| 2021-12-05 15:41 | Heparin | Damon Richter | Citace | me |
| 2021-12-05 15:39 | Heparin | Damon Richter | Citace | me |
| 2021-12-05 15:38 | Heparin | Damon Richter | Citace | me |
| 2021-12-05 15:36 | Heparin | Damon Richter | Citace | me |
| 2021-12-05 15:29 | Heparin | Damon Richter | Citace | me |
| 2021-12-05 15:19 | Heparin | Damon Richter | Citace | me |
| 2021-12-05 15:18 | Heparin | Damon Richter | Citace | me |
| 2021-12-05 15:07 | Heparin | Damon Richter | Citace | me |
| 2021-12-05 15:02 | Heparin | Damon Richter | me | |
| 2021-12-05 15:01 | Heparin | Damon Richter | Citace | me |
| 2021-12-05 15:00 | Heparin | Damon Richter | me | |
| 2021-12-05 14:58 | Heparin | Damon Richter | me | |
| 2021-12-05 14:57 | Heparin | Damon Richter | me | |
| 2021-12-05 14:56 | Heparin | Damon Richter | me | |
| 2021-12-05 14:21 | Heparin | Damon Richter | me | |
| 2021-12-05 14:17 | Heparin | Damon Richter | me | |
| 2021-12-05 14:11 | Heparin | Damon Richter | me | |
| 2021-12-05 14:05 | Heparin | Damon Richter | Format, sources and other | me |
| 2021-12-05 13:50 | Heparin | Structure and formate, picture of heparin | ||
| 2021-12-05 13:25 | Heparin | Damon Richter | me | |
| 2021-12-05 13:24 | Heparin | Damon Richter | me | |
| 2021-01-12 12:02 | Heparin | Madalena | https://www.wikiskripta.eu/index.php?title=Heparin&curid=7441 |
Flags: me - minor edit, d - deleted.
